Investing Profile

Karen Wagner

General Partner at Ysios Capital

Your Intro Paths to Karen Wagner

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Karen is a member of

Mckinsey & Company Network

749 CONNECTIONS

Roche Network

51 CONNECTIONS

Independent Consultant Network

40 CONNECTIONS

Aura Entertainment, Shooting Gallery, Morgan Creek Productions, Other Network

32 CONNECTIONS

Aura Entertainment, Shooting Gallery, Morgan Creek Productions, Other Network

32 CONNECTIONS

Find Karen Wagner on

Current Investing Position

Ysios Capital General Partner

Investment Range

$1M - $7.5M

Sweet Spot

$1M

Investments On Record

Current Fund Size

€126.4M

Karen Wagner is on these Sector & Stage Rankings

Karen Wagner's Investments On Record (3)

Company	StageDateRound Size	Total Raised
Cytoki Pharma	Series AMay 2021$45M	$45M
Co-investors: Dani Bach (+ND Capital), Isabelle de Cremoux (Seventure Partners)
Galecto	Series DSep 2020$64M Series COct 2018$90M	$150M
Co-investors: Chau Khuong (OrbiMed)
KALA BIO	Series BApr 2014$23M	$110M
Co-investors: Kevin Bitterman (Polaris Partners), Robert Tepper (Third Rock Ventures)

Karen Wagner's Experience

Consultant Mckinsey & CompanyPresent

Director Business Development Ingenium Pharmaceuticals AGPresent

Director Business Development Ingenium Pharmaceuticals GmbHPresent

VP Licensing Glycart Biotechnology AGPresent

VP Licensing Aura Entertainment, Shooting Gallery, Morgan Creek Productions, OtherPresent

Global Alliance Director RochePresent

Global Alliance Director F. Hoffmann-La Roche LtdPresent

Consultant Business Development Aura Entertainment, Shooting Gallery, Morgan Creek Productions, OtherPresent

Consultant Business Development Independent ConsultantPresent

General Partner Ysios CapitalPresent

Karen Wagner's Education

University of Konstanz PhD Molecular and Cell Biology

Universität Konstanz PhD Molecular and Cell Biology

Investors who invest with Karen Wagner

Scouts & Angels Affiliated With Karen Wagner